This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Aceragen Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Aceragen.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth39.7%
Revenue growth rate-161.8%
Future return on equityn/a
Analyst coverage

Low

Last updated01 Mar 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:V9Z - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2024N/A-63N/AN/A1
12/31/2023N/AN/AN/AN/A1
3/31/20237-41-30-30N/A
12/31/20225-23-24-24N/A
9/30/20220-16-15-15N/A
6/30/2022N/A-18-17-17N/A
3/31/2022N/A-20-20-20N/A
12/31/2021N/A97-25-25N/A
9/30/2021N/A24-28-28N/A
6/30/2021N/A9-31-31N/A
3/31/2021N/A-8-33-33N/A
12/31/2020N/A-113-34-34N/A
9/30/2020N/A-87-37-37N/A
6/30/2020N/A-78-40-40N/A
3/31/20201-65-42-42N/A
12/31/20191-85-45-44N/A
9/30/20192-45-46-46N/A
6/30/20192-46-47-47N/A
3/31/20190-51-51-51N/A
12/31/20181-60-52-52N/A
9/30/20181-63-52-52N/A
6/30/20181-66-52-52N/A
3/31/20181-71-53-52N/A
12/31/20171-66-55-55N/A
9/30/201716-50-39-39N/A
6/30/201716-49-38-38N/A
3/31/201716-41-33-33N/A
12/31/201616-38N/A-28N/A
9/30/20161-51N/A-42N/A
6/30/20161-50N/A-43N/A
3/31/20161-49N/A-43N/A
12/31/20150-49N/A-43N/A
9/30/20150-49N/A-44N/A
6/30/20150-47N/A-40N/A
3/31/20150-42N/A-36N/A
12/31/20140-39N/A-31N/A
9/30/20140-34N/A-26N/A
6/30/20140-29N/A-23N/A
3/31/20140-26N/A-21N/A
12/31/20130-21N/A-17N/A
9/30/20130-21N/A-17N/A
6/30/20130-21N/A-17N/A
3/31/20130-19N/A-18N/A
12/31/20120-22N/A-20N/A
9/30/20120-26N/A-19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if V9Z's forecast earnings growth is above the savings rate (0.4%).

Earnings vs Market: Insufficient data to determine if V9Z's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if V9Z's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: V9Z is forecast to have no revenue next year.

High Growth Revenue: V9Z is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if V9Z's Return on Equity is forecast to be high in 3 years time


Discover growth companies